Singapore: With a view to expand into the lucrative Asian markets, two major medical companies in Japan have planned to ...
For the first time, Nihon University will organize an international symposium on Medical-Engineering Collaboration with ...
Physicians at 23 brain cancer centers in Japan are now certified to provide Optune to recurrent glioblastoma patients on...
Norway-based Serendex Pharmaceuticals A/S has entered into a non-binding term sheet with a pharma company regarding Sere...
Singapore: Plasticell, the biotechnology company specialising in high throughput technologies for directed stem cell di...
OphthaliX Inc., a clinical-stage company focused on developing therapeutic products for the treatment of ophthalmic diso...
Singapore: Sigma-Aldrich's innovative biological products and services business Sigma Life Science signed an exclusive c...
Singapore: Sun Pharma has announced the acquisition of 14 established prescription brands from Novartis AG and Novartis ...
French pharma giant Sanofi has announced that the Ministry of Health, Labor and Welfare (MHLW) in Japan has granted mark...
Singapore: NextDocs, the global leader in compliance solutions for regulated industries, announced that it has expanded ...
‎Singapore: ReSearch Pharmaceutical Services (RPS) and Japan-based Asklep have formed a joint venture company (JVC...
Tokyo: Nipro Corporation, headquartered in Osaka, Japan, has signed a definitive agreement to acquire US headquartered ...
Singapore: The US arm of Japan's Eisai has entered into a worldwide collaboration with Purdue Pharma to develop and comm...
Tokyo-headquartered Dentsu Inc announced that the company's corporate venture capital arm Dentsu Ventures Global Fund ha...
Japanese pharmaceutical major Eisai Co. Ltd. has submitted applications to regulatory authorities in Japan, United State...
Singapore: Astellas Pharma and ClearPath Development Company have announced a strategic partnership to form a portfolio ...
Singapore: Eisai published the results of its 'adjunctive perampanel for refractory partial-onset seizures: randomized p...
Singapore: US FDA approved Eisai's Aciphex Sprinkle delayed-release capsules 5mg and 10mg for the treatment of gastroeso...
